Bassim Djebabri, PhD

Bassim Djebabri, PhD has a diverse work experience spanning various roles in the field of sales and scientific research. Their most recent position was as a Senior Sales Executive at STARLIMS, starting in February 2023. Prior to that, they worked as a Senior Account Executive at Benchling from June 2020 to February 2023.

Bassim also has experience in advisory roles, having served as an Advisor at Pangea from June 2020 to May 2022.

Before their roles in sales, Bassim gained valuable experience in scientific research and project management. Bassim worked as a Senior Lead Scientist at the University of Liverpool from April 2013 to November 2013, and as a Biomarker Project Leader at Medicines Evaluation Unit from April 2012 to April 2013.

Bassim has also held positions in leading companies such as Thermo Fisher Scientific and Hologic, Inc. At Thermo Fisher Scientific, they served as a Senior Sales Specialist from January 2018 to June 2020, and as a Life Science Sales Specialist from November 2013 to July 2016. At Hologic, Inc., they held the position of Key Accounts Sales Manager, Molecular Diagnostics from November 2016 to January 2018.

Additionally, Bassim has experience as a Sales Manager at Philips, where they worked in the Biocell EMEA division from July 2016 to November 2016.

Their work experience also includes a role as a Commercial Independent Distributor at MonaVie from January 2009 to December 2013.

Throughout their career, Bassim has developed a strong background in sales, project management, and scientific research, making him a well-rounded and experienced professional in their field.

Dr. Bassim Djebabri earned a Bachelor of Science (BSc) degree in Medical Genetics from the University of Leicester in 2005. Subsequently, they pursued a Postgraduate Research Diploma in Molecular Genetics at the same institution from 2005 to 2006. Dr. Djebabri further advanced their education and obtained a Doctor of Philosophy (PhD) degree in Immunology from the University of Leicester, completing their studies in 2010.